Clinical Trials Browser

Phase 2 × Fenretinide × Gynecologic × Clear all

NCT00026091 2013-03-25

Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial